In the real-world, Pluvicto™ showed 13.5 months median PFS in chemo-naïve patients with PSMA-positive mCRPC; Real‑world evidence showed Pluvicto achieved longer PFS when init ...
Influencers and celebrities are using unapproved peptide therapies. What does the science say about them?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results